James Ellsmore

King & Wood Mallesons


Results 1 to 5 of 28
Most popular |Most recent

Lessons for IP commercialisation from the LESANZ Annual Conference 2019

Australia, Global - May 28 2019 The Licensing Executives Society Australia & New Zealand held its annual conference in Brisbane this month. The three-day event was a fantastic…

Scott Bouvier, Karen Litherland.

Generic supplier obtains substantial reduction in damages awarded against it

Australia - November 12 2018 Earlier this month, we reported on the Full Court’s decision in Generic Health v Bayer [2018] FCAFC 183, in which the Full Court clarified that when…

Gene editing and genetic engineering techniques

Australia - June 7 2018 New genome editing techniques, such as CRISPR/Cas9, have made editing genomic material cheap, efficient and accessible. These new techniques have…

High Court states the obvious: AstraZeneca AB v Apotex Pty Ltd appeal decided

Australia - September 3 2015 In a widely anticipated decision, the High Court has upheld a decision of the Full Federal Court (which was made by five, rather than the usual three…

Suzy Madar, Kim O'Connell.

Generic Health succeeds in invalidating patent for aripiprazole: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) [2015] FCA 634

Australia - July 7 2015 Generic Health is perhaps a step closer to bringing its generic version of the antipsychotic drug aripiprazole to market in Australia after Justice…